ruboxistaurin has been researched along with Chronic Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadian, R; Jernigan, NL; Resta, TC; Sheak, JR; Walker, BR; Weise-Cross, L; Yan, S | 1 |
Shah, SV | 1 |
Benson, C; Seger, M; Voelker, J | 1 |
Shah, SV; Swaminathan, S | 1 |
2 review(s) available for ruboxistaurin and Chronic Disease
Article | Year |
---|---|
Progress toward novel treatments for chronic kidney disease.
Topics: Amides; Anticoagulants; Antihypertensive Agents; Bicarbonates; Chronic Disease; Enzyme Inhibitors; Fumarates; Glycosaminoglycans; Humans; Indoles; Iron Chelating Agents; Kidney Diseases; Kidney Failure, Chronic; Maleimides; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridones; Renin; Renin-Angiotensin System | 2010 |
Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
Topics: Biomarkers; Chronic Disease; Diabetic Nephropathies; Disease Progression; Drugs, Investigational; Glycation End Products, Advanced; Humans; Indoles; Iron; Kidney; Kidney Diseases; Maleimides; Oxidative Stress; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Reactive Oxygen Species; Treatment Outcome; Vitamin B Complex | 2008 |
1 trial(s) available for ruboxistaurin and Chronic Disease
Article | Year |
---|---|
Inhibition of PKC beta by ruboxistaurin does not enhance the acute blood pressure response to nitroglycerin.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypotension, Orthostatic; Indoles; Infusions, Intravenous; Male; Maleimides; Middle Aged; Nitroglycerin; Protein Kinase C; Protein Kinase C beta; Treatment Outcome; Vasodilator Agents | 2007 |
1 other study(ies) available for ruboxistaurin and Chronic Disease
Article | Year |
---|---|
PKCĪ² and reactive oxygen species mediate enhanced pulmonary vasoconstrictor reactivity following chronic hypoxia in neonatal rats.
Topics: Animals; Animals, Newborn; Chronic Disease; Cyclic N-Oxides; Enzyme Inhibitors; Female; Free Radical Scavengers; Hypoxia; Indoles; Maleimides; Organophosphorus Compounds; Oxidative Stress; Pregnancy; Protein Kinase C beta; Pulmonary Artery; Pulmonary Circulation; Rats; Reactive Oxygen Species; Spin Labels; Ubiquinone; Vasoconstriction; Vasoconstrictor Agents | 2020 |